Properdin and Complement Activation: A Fresh Perspective

E-ISSN： 1873-5592|9|2|158-164

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.2, 2008-02, pp. : 158-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Complement Properdin in Renal Ischemia-Reperfusion Injury

Current Gene Therapy, Vol. 17, Iss. 6, 2018-03 ,pp. : 411-423

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of an anti-properdin MoAb in two models of complement-mediated tissue in jury

By Parent J.B. Benzing W.C. Gupta-Bansal R. Convery M. Anderson R. Brunden K.R.

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 68-68

Elsevier

Access to resources Recommend Favorite

Effect of complement mediators on eosinophil activation

By DiScipio R.G. Sriramarao P. Schraufstatter I.

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 93-93

Elsevier

Access to resources Recommend Favorite

Species and pathway-specific activation of complement by a phosphorothioate oligonucleotide

By Henry S. Jagels M. Hugli T. Giclas P.

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 97-97

Elsevier

Access to resources Recommend Favorite

Modulators of complement activation: a patent review (2008 – 2013)

By Larghi Enrique L Kaufman Teodoro S

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 6, 2014-06 ,pp. : 665-686

Informa Healthcare

Access to resources Recommend Favorite